{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:31:05Z","timestamp":1773916265331,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T00:00:00Z","timestamp":1153526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T00:00:00Z","timestamp":1153526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s10637-006-9000-0","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T17:12:30Z","timestamp":1153501950000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia\/lymphoma agents against human leukemia\/lymphoma cell lines"],"prefix":"10.1007","volume":"25","author":[{"given":"Yasuhiko","family":"Kano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,22]]},"reference":[{"key":"9000_CR1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.272.5260.371","volume":"272","author":"AP Wolffe","year":"1996","unstructured":"Wolffe AP (1996) Histone deacetylase: a regulator of transcription. Science 272:371\u2013372","journal-title":"Science"},{"key":"9000_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0959-437X(99)80006-9","volume":"9","author":"T Kouzarides","year":"1999","unstructured":"Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet 9:40\u201348","journal-title":"Curr Opin Genet"},{"key":"9000_CR3","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","volume":"92","author":"PA Marks","year":"2000","unstructured":"Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210\u20131216","journal-title":"J Natl Cancer Inst"},{"key":"9000_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1043-2760(01)00438-6","volume":"12","author":"OH Kramer","year":"2001","unstructured":"Kramer OH, Gottlicher M, Heinzel T (2001) Histone deacetylase as a therapeutic target. Trends Endocrin Met 12:294\u2013300","journal-title":"Trends Endocrin Met"},{"key":"9000_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7164\/antibiotics.47.301","volume":"47","author":"H Ueda","year":"1994","unstructured":"Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M (1994) FR901228 a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No 968 I Taxonomy fermentation isolation physico-chemical and biological properties and antitumor activity. J Antibiot 47:301\u2013310","journal-title":"J Antibiot"},{"key":"9000_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1006\/excr.1998.4027","volume":"241","author":"H Nakajima","year":"1998","unstructured":"Nakajima H, Kim YB, Terano H, Yoshida M, Horinouchi S (1998) FR901228 a potent antitumor antibiotic is a novel histone deacetylase inhibitor. Exp Cell Res 241:126\u2013133","journal-title":"Exp Cell Res"},{"key":"9000_CR7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood.V94.4.1401.416k30_1401_1408","volume":"94","author":"JC Byrd","year":"1999","unstructured":"Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR (1999) Depsipeptide FR901228: a novel therapeutic agent with selective in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 94:1401\u20131408","journal-title":"Blood"},{"key":"9000_CR8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1349-7006.2000.tb00899.x","volume":"91","author":"M Murata","year":"2000","unstructured":"Murata M, Towatari M, Kosugi H, Tanimoto M, Ueda R, Saito H, Naoe T (2000) Apoptotic cytotoxic effects of a histone deacetylase inhibitor FR901228 on malignant lymphoid cells. Jpn J Cancer Res 91:1154\u20131160","journal-title":"Jpn J Cancer Res"},{"key":"9000_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ijc.10921","volume":"104","author":"J Tsurutani","year":"2003","unstructured":"Tsurutani J, Soda H, Oka M, Suenaga M, Doi S, Nakamura Y, Nakatomi K, Shiozawa K, Amada YY, Kamihira S, Kohno S (2003) Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. Int J Cancer 104:238\u2013242","journal-title":"Int J Cancer"},{"key":"9000_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7164\/antibiotics.47.315","volume":"47","author":"H Ueda","year":"1995","unstructured":"Ueda H, Manda T, Matsumoto S, Mukumoto S, Nishigaki F, Kawamura I, Shimomura K (1995) FR901228 a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No 968. III. Antitumor activities on experimental tumors in mice. J Antibiot 47:315\u2013323","journal-title":"J Antibiot"},{"key":"9000_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0006-2952(02)01261-3","volume":"64","author":"Y Sasakawa","year":"2002","unstructured":"Sasakawa Y, Naoe Y, Inoue T, Sasakawa T, Matsuo M, Manda T, Mutoh S (2002) Effects of FK228 a novel histone deacetylase inhibitor on human lymphoma U-937 cells in vitro and in vivo. Biochem Pharmacol 64:1079\u20131090","journal-title":"Biochem Pharmacol"},{"key":"9000_CR12","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","volume":"98","author":"RL Piekarz","year":"2001","unstructured":"Piekarz RL, Robey R, Sandor V, Bakke S, Wilson WH, Dahmoush L, Kingma DM, Turner ML, Altemus R, Bates SE (2001) Inhibitor of histone deacetylation depsipeptide FR901228 in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood 98:2865\u20132868","journal-title":"Blood"},{"key":"9000_CR13","first-page":"718","volume":"8","author":"V Sandor","year":"2002","unstructured":"Sandor V, Bakke S, Robey RW, Kang MH, Blagosklonny MV, Bender J, Brooks R, Piekarz RL, Tucker E, Figg WD, Chan KK, Goldspiel B, Fojo AT, Balcerzak SP, Bates SE (2002) Phase I Trial of the Histone Deacetylase Inhibitor Depsipeptide FR901228 NSC630176 in Patients with Refractory Neoplasms. Clin Cancer Res 8:718\u2013728","journal-title":"Clin Cancer Res"},{"key":"9000_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","volume":"105","author":"JC Byrd","year":"2005","unstructured":"Byrd JC, Marcucci G, Parthun MR, Xiao JJ, Klisovic RB, Moran M, Lin TS, Liu S, Sklenar AR, Davis ME, Lucas DM, Fischer B, Shank R, Tejaswi SL, Binkley P, Wright J, Chan KK, Grever MR (2005) A phase 1 and pharmacodynamic study of depsipeptide FK228 in chronic lymphocytic leukemia and acute myeloid leukemia. Blood 105:959\u2013967","journal-title":"Blood"},{"key":"9000_CR15","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1038\/sj.onc.1206498","volume":"22","author":"N Nishimura","year":"2003","unstructured":"Nishimura N, Furukawa Y, Sutheesophon K, Nakamura M, Kishi K, Okuda K, Sato Y, Kano Y (2003) Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18\/INK4c. Oncogene 22:4074\u20134082","journal-title":"Oncogene"},{"key":"9000_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0145-2126(91)90112-7","volume":"15","author":"Y Kano","year":"1991","unstructured":"Kano Y, Sakamoto S, Kasahara T, Akutsu M, Inoue Y, Miura Y (1991) In vitro effects of amsacrine in combination with other anti-cancer agents. Leukemia Res 15:1059\u20131066","journal-title":"Leukemia Res"},{"key":"9000_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85\u201393","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9000_CR18","first-page":"351","volume":"48","author":"Y Kano","year":"1988","unstructured":"Kano Y, Ohnuma T, Okano T, Holland JF (1988) Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 48:351\u2013356","journal-title":"Cancer Res"},{"key":"9000_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1182\/blood.V97.7.1999","volume":"97","author":"Y Kano","year":"2001","unstructured":"Kano Y, Akutsu M, Tsunoda S, Mano H, Sato Y, Honma Y, Furukawa Y (2001) In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents. Blood 97:1999\u20132007","journal-title":"Blood"},{"key":"9000_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s002800050790","volume":"42","author":"Y Kano","year":"1998","unstructured":"Kano Y, Akutsu M, Tsunoda S, Suzuki K, Adachi K (1998) In vitro schedule-dependent interaction between paclitaxel and SN-38 the active metabolite of irinotecan in human carcinoma cell lines. Cancer Chemother Pharmacol 42:91\u201398","journal-title":"Cancer Chemother Pharmacol"},{"key":"9000_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jcp.20235","volume":"203","author":"K Sutheesophon","year":"2005","unstructured":"Sutheesophon K, Nishimura N, Kobayashi Y, Furukawa Y, Kawano M, Itoh K, Kano Y, Ishii H, Furukawa Y (2005) Involvement of the tumor necrosis factor TNF\/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide FK228. J Cell Physiol 203:387\u2013397","journal-title":"J Cell Physiol"},{"key":"9000_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1054\/bjoc.2000.1327","volume":"83","author":"V Sandor","year":"2000","unstructured":"Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV, Bates SE (2000) P21-dependent G1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Br J Cancer 83:817\u2013825","journal-title":"Br J Cancer"},{"key":"9000_CR23","first-page":"2705","volume":"24","author":"T Kawano","year":"2004","unstructured":"Kawano T, Horiguchi-Yamada J, Iwase S, Akiyama M, Furukawa Y, Kano Y, Yamada H (2004) Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. Anticancer Res 24:2705\u20132712","journal-title":"Anticancer Res"},{"key":"9000_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/94.7.504","volume":"94","author":"X Yu","year":"2002","unstructured":"Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA, Schrump DS (2002) Modulation of p53 ErbB1 ErbB2 and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Natl Cancer Inst 94:504\u2013513","journal-title":"J Natl Cancer Inst"},{"key":"9000_CR25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sj.onc.1209072","volume":"25","author":"Y Kobayashi","year":"2006","unstructured":"Kobayashi Y, Ohtsuki M, Murakami T, Kobayashi T, Sutheesophon K, Kitayama H, Kano Y, Kusano E, Nakagawa H, Furukawa Y (2006) Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma. Oncogene 25:512\u2013524","journal-title":"Oncogene"},{"key":"9000_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1182\/blood-2002-12-3794","volume":"102","author":"JL Aron","year":"2003","unstructured":"Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, Lucas DM, Reed JC, Grever MR, Byrd JC (2003) Depsipeptide FR901228 induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase-8-mediated apoptosis and downregulation of c-FLIP protein. Blood 102:652\u2013658","journal-title":"Blood"},{"key":"9000_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000089471","volume":"115","author":"K Sutheesophon","year":"2006","unstructured":"Sutheesophon K, Kobayashi Y, Takatoku M, Ozawa K, Kano Y, Ishii H, Furukawa Y (2006) Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by proteasome inhibitor bortezomib. Acta Haematol 115:78\u201390","journal-title":"Acta Haematol"},{"key":"9000_CR28","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1038\/sj.onc.1205777","volume":"21","author":"F Blanchard","year":"2002","unstructured":"Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H (2002) FR901228 an inhibitor of histone deacetylases increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Oncogene 21:6264\u20136277","journal-title":"Oncogene"},{"key":"9000_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.1602","volume":"97","author":"HJ Kwon","year":"2002","unstructured":"Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW (2002) Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer 97:290\u2013296","journal-title":"Int J Cancer"},{"key":"9000_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0006-291X(02)02787-0","volume":"300","author":"Y Mie Lee","year":"2003","unstructured":"Mie Lee Y, Kim SH, Kim HS, Jin Son M, Nakajima H, Jeong Kwon H, Kim KW (2003) Inhibition of hypoxia-induced angiogenesis by FK228 a specific histone deacetylase inhibitor via suppression of HIF-1alpha activity. Biochem Biophys Res Commun 300:241\u2013246","journal-title":"Biochem Biophys Res Commun"},{"key":"9000_CR31","first-page":"109","volume-title":"Cancer chemotherapy and biotherapy","author":"E Chu","year":"2000","unstructured":"Chu E, Allegra CJ (2000) Antifolates. In: Chabner BA, Longo DL (eds) Cancer chemotherapy and biotherapy. Lippincott-Raven, Philadelphia, pp 109\u2013148"},{"key":"9000_CR32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/cbt.317","volume":"1","author":"M Kitazono","year":"2002","unstructured":"Kitazono M, Bates S, Fok P, Fojo T, Blagosklonny MV (2002) The histone deacetylase inhibitor FR901228 (desipeptide restores expression and function of pseudo-null p53. Cancer Biol Ther 1:665\u2013668","journal-title":"Cancer Biol Ther"},{"key":"9000_CR33","first-page":"2118","volume":"63","author":"C Yu","year":"2003","unstructured":"Yu C, Rahmani M, Almenara J, Subler M, Krystal G, Conrad D, Varticovski L, Dent P, Grant S (2003) Histone Deacetylase Inhibitors Promote STI571-mediated Apoptosis in IMATINIB-sensitive and -resistant Bcr\/Abl+ Human Myeloid Leukemia Cells. Cancer Res 63:2118\u20132126","journal-title":"Cancer Res"},{"key":"9000_CR34","first-page":"93","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum MC (1989) What is synergy? Pharmacol Rev 41:93\u2013141","journal-title":"Pharmacol Rev"},{"key":"9000_CR35","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","volume":"10","author":"L Zhao","year":"2004","unstructured":"Zhao L, Wientjes MG, Au JL (2004) Evaluation of combination chemotherapy: integration of nonlinear regression curve shift isobologram and combination index analyses. Clin Cancer Res 10:7994\u20138004","journal-title":"Clin Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-006-9000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-006-9000-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-006-9000-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-006-9000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:19:29Z","timestamp":1678558769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-006-9000-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,22]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["9000"],"URL":"https:\/\/doi.org\/10.1007\/s10637-006-9000-0","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,22]]},"assertion":[{"value":"22 July 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}